Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ: CRSP )

53.04 +0.82 (+1.57%)
Streaming Delayed Price Updated: 3:37 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Why CRISPR Therapeutics Is Trading Higher Today
The Price And Volume Action In CRISPR Therapeutics's Stock Today CRISPR Therapeutics's (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10... 
Via Benzinga
3 Top Value Stocks in Healthcare to Buy Right Now
Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market. 
Via The Motley Fool
46 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it... 
Via Benzinga
Vertex Pharmaceuticals Raises Bet on CRISPR Therapeutics
The amended collaboration agreement comes with a big up-front payment. 
Via The Motley Fool
Mid-Afternoon Market Update: Dow Tumbles 370 Points; Kansas City Southern Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 1.09% to 33,706 while the NASDAQ fell 1.30% to 13,733.94. The S&P also fell, dropping 0.97% to 4,122.80. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
31 Stocks Moving In Tuesday's Mid-Day Session
Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) gained 20.8% to $5.32 after dropping more than 10% on Monday. Takung Art Co., Ltd. (NASDAQ: TKAT) shares surged 18.2% to $21.08... 
Via Benzinga
Why Crispr, KalVista And Syndax Are Moving Today
CRISPR Therapeutics AG (NASDAQ: CRSP), Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) and KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) were among the early movers in the biopharma... 
Via Benzinga
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
A "sell" rating is one thing, but a 50% price target? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it. 
Via InvestorPlace
Is bluebird bio a Bad News Buy?
The biotech has had a rough couple of years. 
Via The Motley Fool
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
Regulatory and drug-pricing worries have knocked biotech stocks off their pedestal. After hitting a high point in February, biotech stocks have fallen 20%. 
Via Investor's Business Daily
Exposures COVID-19
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.